Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
METiS Pharmaceuticals logo — company profile

METiS Pharmaceuticals

Founded 2020 6 employees Series C Total: $336.00M AI, Biopharma +3

General Information

Company Name METiS Pharmaceuticals
Founded Year 2020
Employees 6
Industries AI, Biopharma, Biotechnology +2
Funding Stage Series C
Social

Get notified when METiS Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About METiS Pharmaceuticals

METiS Pharmaceuticals, founded in 2020, is an innovative biotechnology company leveraging artificial intelligence (AI) to drive targeted drug delivery technology for developing more effective drugs. The firm integrates cutting-edge AI technology with traditional pharmaceutical R&D, aiming to accelerate the R&D of innovative drugs in a more efficient and precise way. Its technology platforms support the entire pharmaceutical ecosystem and lead industry innovation. The company secured a notable $100.00M Series C investment on 22 June 2024 from CICC Capital and China Taiping Insurance. The firm operates within the AI, Biopharma, Biotechnology, Medical Devices, and Pharmaceutical industries.

Taxonomy: Drug Delivery, Pharmaceutical R&D, Innovation, AI Technology, Precision Medicine, Nucleic Acid Drug Development, Quantum Simulation, Targeted Drug Delivery, Innovative Drug Development, Precision Drug Design, Pharmaceutical Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 2
Investor
•••• •••• 		22 Jun 2024
Series B •••••• 8
Investor Investor Investor
•••• •••• 		06 Apr 2022
Series A •••••• - 13 Dec 2021
Angel Round •••••• - 23 Mar 2020

METiS Pharmaceuticals Alternatives & Competitors

METiS Pharmaceuticals vs
Bostal Drug Delivery
Bostal Drug Delivery

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
METiS Pharmaceuticals vs
Jiangsu Vcare PharmaTech Co., Ltd.
Jiangsu Vcare PharmaTech Co., Ltd.

Advancing pharmaceutical innovation through ground-breaking R&D, seamless generic drug technology tr...

Series C
8 employees
Biopharma, Biotechnology
METiS Pharmaceuticals vs
Harmonicare Pharmaceuticals
Harmonicare Pharmaceuticals

Committed to pioneering the future of innovative drug development

Series D
Pharmaceutical

FAQ About METiS Pharmaceuticals

METiS is an innovative biotechnology company driven by artificial intelligence (AI) that harnesses targeted drug delivery technology to develop more effective drugs for patients. Through the integration of cutting-edge AI technology and traditional pharmaceutical R&D, METiS aims to accelerate the R&...
METiS Pharmaceuticals was founded in 2020.
METiS Pharmaceuticals operates in the following industries: AI, Biopharma, Biotechnology, Medical Devices, Pharmaceutical.
METiS Pharmaceuticals has approximately 6 employees.
METiS Pharmaceuticals has completed 4 funding rounds, raising a total of $336.00M. The latest funding stage is Series C.
Top alternatives and competitors to METiS Pharmaceuticals include Bostal Drug Delivery, Jiangsu Vcare PharmaTech Co., Ltd., Harmonicare Pharmaceuticals, Treat U, Softhale. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
METiS Pharmaceuticals and Bostal Drug Delivery are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors METiS Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy